Donald Robert Schemel - 04 Oct 2022 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role: Director, 10%+ Owner
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol: PBLA
Transactions as of: 04 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Oct 2022, 17:26:46 UTC
Previous filing: 27 May 2021
Next filing: 29 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBLA	Common Stock	Purchase		+200,000	+71%		482,654	04 Oct 2022	By Spouse	F1
holding	PBLA	Common Stock						96,619	04 Oct 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBLA	Warrants (right to buy)	Purchase	$0	+300,000		$0.000000	300,000	04 Oct 2022	Common Stock	300,000	$0.3000	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.